Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Cilong Chu, Zixuan Rao, Qingshan Pan & Wufu Zhu. (2022) An updated patent review of small-molecule c-Met kinase inhibitors (2018-present). Expert Opinion on Therapeutic Patents 32:3, pages 279-298.
Read now
Read now
Xiaofei Li, Jia Wan, Zhenping Wu, Juncai Tu, Yongtao Hu, Shuang Wu & Lianqing Lou. (2018) Fatal adverse events with molecular targeted agents in the treatment of advanced hepatocellular carcinoma: a meta-analysis of randomized controlled trials. Drug Design, Development and Therapy 12, pages 3043-3049.
Read now
Read now
Eva Juárez-Hernández, Daniel Motola-Kuba, Norberto Carlos Chávez-Tapia, Misael Uribe & Varenka Barbero Becerra. (2017) Biomarkers in hepatocellular carcinoma: an overview. Expert Review of Gastroenterology & Hepatology 11:6, pages 549-558.
Read now
Read now
Articles from other publishers (15)
Miner Hu, Xiaojun Xia, Lichao Chen, Yunpeng Jin, Zhenhua Hu, Shudong Xia & Xudong Yao. (2023) Emerging biomolecules for practical theranostics of liver hepatocellular carcinoma. Annals of Hepatology 28:6, pages 101137.
Crossref
Crossref
Kai-Chun Zhao, Yi-Ying Zhuang, Tian-Hong Jing, Guang-Hui Shi, Lin Guo, Xiao-Li Zhao, Yong Lu & Ye Liu. (2023) Pd-catalyzed tandem bis-hydroaminocarbonylation of terminal alkynes for synthesis of N-aryl substituted succinimides with involvement of ionic P, O-hybrid ligand. Journal of Catalysis 417, pages 248-259.
Crossref
Crossref
Jiahui Yan, Lin Chen, Li Zhang, Zhaohuan Zhang, Yong Zhao, Yuan Wang & Jie Ou. (2022) New Insights Into the Persistent Effects of Acute Exposure to AFB1 on Rat Liver. Frontiers in Microbiology 13.
Crossref
Crossref
Shankun Zhao, Weizhou Wu, Hao Jiang, Lei Ma, Chengyi Pan, Chong Jin, Jinggang Mo, Liezhi Wang & Kunpeng Wang. (2021) Selective Inhibitor of the c-Met Receptor Tyrosine Kinase in Advanced Hepatocellular Carcinoma: No Beneficial Effect With the Use of Tivantinib?. Frontiers in Immunology 12.
Crossref
Crossref
Federico Riu, Luca Sanna, Roberta Ibba, Sandra Piras, Valentina Bordoni, M. Andrea Scorciapino, Michele Lai, Simona Sestito, Luigi Bagella & Antonio Carta. (2021) A comprehensive assessment of a new series of 5′,6′-difluorobenzotriazole-acrylonitrile derivatives as microtubule targeting agents (MTAs). European Journal of Medicinal Chemistry 222, pages 113590.
Crossref
Crossref
Consolato M. Sergi. 2021. Liver Cancer. Liver Cancer
1
38
.
Víctor Samper Barceló & Stefan Bienz. (2018)
Synthesis of Highly Substituted 3-Pyrrolin-2-ones from
N,N
-Disubstituted α-Amino Acids
. The Journal of Organic Chemistry 83:5, pages 2734-2743.
Crossref
Crossref
Peng Han, Hali Li, Xian Jiang, Bo Zhai, Gang Tan, Dali Zhao, Haiquan Qiao, Bing Liu, Hongchi Jiang & Xueying Sun. (2017) Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells. Molecular Oncology 11:3, pages 320-334.
Crossref
Crossref
M. Simonelli, P. Zucali, A. Santoro, M.B. Thomas, F.G. de Braud, H. Borghaei, J. Berlin, C.S. Denlinger, C. Noberasco, L. Rimassa, T.-Y. Kim, P.A. English, A. Abbattista, C. Gallo Stampino, M. Carpentieri & J.A. Williams. (2016) Phase I study of PF-03446962, a fully human monoclonal antibody against activin receptor-like kinase-1, in patients with hepatocellular carcinoma. Annals of Oncology 27:9, pages 1782-1787.
Crossref
Crossref
Yan-li Bai, Hong-chang Yuan, Dong-tao Zhang, Yuan Liu & Yin Zhang. (2016) Quantitative analysis of tivantinib in rat plasma using ultra performance liquid chromatography with tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis 126, pages 98-102.
Crossref
Crossref
Yuxi Wang, Hang Zhang, Beno?t Gigant, Yamei Yu, Yangping Wu, Xiangzheng Chen, Qinhuai Lai, Zhaoya Yang, Qiang Chen & Jinliang Yang. (2016) Structures of a diverse set of colchicine binding site inhibitors in complex with tubulin provide a rationale for drug discovery. FEBS Journal 283:1, pages 102-111.
Crossref
Crossref
Maocai Yan, Huiyun Wang, Qibao Wang, Zhen Zhang & Chunyan Zhang. (2016) Allosteric inhibition of c-Met kinase in sub-microsecond molecular dynamics simulations induced by its inhibitor, tivantinib. Physical Chemistry Chemical Physics 18:15, pages 10367-10374.
Crossref
Crossref
Shunchao Yan, Xin Jiao, Huawei Zou & Kai Li. (2015) Prognostic significance of c-Met in breast cancer: a meta-analysis of 6010 cases. Diagnostic Pathology 10:1.
Crossref
Crossref
Jiang Chen, Renan Jin, Jie Zhao, Jinghua Liu, Hanning Ying, Han Yan, Senjun Zhou, Yuelong Liang, Diyu Huang, Xiao Liang, Hong Yu, Hui Lin & Xiujun Cai. (2015) Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma. Cancer Letters 367:1, pages 1-11.
Crossref
Crossref
Simona Gurzu. (2015) Epithelial-mesenchymal, mesenchymal-epithelial, and endothelial-mesenchymal transitions in malignant tumors: An update. World Journal of Clinical Cases 3:5, pages 393.
Crossref
Crossref